Tags

Type your tag names separated by a space and hit enter

[SARS-CoV-2 infection during pregnancy. Information and proposal of management care. CNGOF].
Gynecol Obstet Fertil Senol. 2020 05; 48(5):436-443.GO

Abstract

A new coronavirus (SARS-CoV-2) highlighted at the end of 2019 in China is spreading across all continents. Most often at the origin of a mild infectious syndrome, associating mild symptoms (fever, cough, myalgia, headache and possible digestive disorders) to different degrees, SARS-Covid-2 can cause serious pulmonary pathologies and sometimes death. Data on the consequences during pregnancy are limited. The first Chinese data published seem to show that the symptoms in pregnant women are the same as those of the general population. There are no cases of intrauterine maternal-fetal transmission, but cases of newborns infected early suggest that there could be vertical perpartum or neonatal transmission. Induced prematurity and cases of respiratory distress in newborns of infected mothers have been described. Pregnancy is known as a period at higher risk for the consequences of respiratory infections, as for influenza, so it seems important to screen for Covid-19 in the presence of symptoms and to monitor closely pregnant women. In this context of the SARS-Covid-2 epidemic, the societies of gynecology-obstetrics, infectious diseases and neonatalogy have proposed a French protocol for the management of possible and proven cases of SARS-Covid-2 in pregnant women. These proposals may evolve on a daily basis with the advancement of the epidemic and knowledge in pregnant women. Subsequently, an in-depth analysis of cases in pregnant women will be necessary in order to improve knowledge on the subject.

Authors+Show Affiliations

Service de gynécologie-obstétrique Colombes, Assistance publique-Hôpitaux de Paris, hôpital Louis-Mourier, université de Paris, 92700 Colombes, France; Infection Control Unit, Bichat University Hospital, Assistance publique-Hôpitaux de Paris, université de Paris, 75018 Paris, France.Service de gynécologie-obstétrique Colombes, Assistance publique-Hôpitaux de Paris, hôpital Louis-Mourier, université de Paris, 92700 Colombes, France; Inserm IAME-U1137, 75000 Paris, France; Groupe de recherche sur les infections pendant la grossesse (GRIG), 75000 Paris, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France; Infection Control Unit, Bichat University Hospital, Assistance publique-Hôpitaux de Paris, université de Paris, 75018 Paris, France.CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France; Service de gynécologie obstétrique, hôpitaux universitaires de Strasbourg, 67000 Strasbourg, France; Infection Control Unit, Bichat University Hospital, Assistance publique-Hôpitaux de Paris, université de Paris, 75018 Paris, France.University Lyon, University Claude-Bernard Lyon 1, 69100 Villeurbanne, France; Hospices civils de Lyon, hôpital de la Croix-Rousse, 69004 Lyon, France; Inserm U846, stem cell and brain research institute, 18, avenue Doyen-Lepine, 69500 Bron, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France; Infection Control Unit, Bichat University Hospital, Assistance publique-Hôpitaux de Paris, université de Paris, 75018 Paris, France.Inserm IAME-U1137, 75000 Paris, France; Service de maladies infectieuses et tropicales, hôpital Bichat Claude-Bernard, université de Paris, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France; Infection Control Unit, Bichat University Hospital, Assistance publique-Hôpitaux de Paris, université de Paris, 75018 Paris, France.Inserm IAME-U1137, 75000 Paris, France; Infection Control Unit, Bichat University Hospital, Assistance publique-Hôpitaux de Paris, université de Paris, 75018 Paris, France.Service de gynécologie-obstétrique Colombes, Assistance publique-Hôpitaux de Paris, hôpital Louis-Mourier, université de Paris, 92700 Colombes, France; Inserm IAME-U1137, 75000 Paris, France; Groupe de recherche sur les infections pendant la grossesse (GRIG), 75000 Paris, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France; Infection Control Unit, Bichat University Hospital, Assistance publique-Hôpitaux de Paris, université de Paris, 75018 Paris, France.CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France; Infection Control Unit, Bichat University Hospital, Assistance publique-Hôpitaux de Paris, université de Paris, 75018 Paris, France.Hôpital Paule-de-Viguier, CHU de Toulouse, 31000 Toulouse, France; Équipe SPHERE, Inserm UMR1027, université Toulouse III, 31000 Toulouse, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France; Infection Control Unit, Bichat University Hospital, Assistance publique-Hôpitaux de Paris, université de Paris, 75018 Paris, France.Inserm IAME-U1137, 75000 Paris, France; Service de maladies infectieuses et tropicales, hôpital Bichat Claude-Bernard, université de Paris, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France; Infection Control Unit, Bichat University Hospital, Assistance publique-Hôpitaux de Paris, université de Paris, 75018 Paris, France.Service de gynécologie obstétrique, maternité Aline-de-Crepy, FHU Prematurity INSERM U1016, hôpital Bichat APHP, université de Paris, Institut Imagine, 75018 Paris, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France; Infection Control Unit, Bichat University Hospital, Assistance publique-Hôpitaux de Paris, université de Paris, 75018 Paris, France.Service de gynécologie-obstétrique Colombes, Assistance publique-Hôpitaux de Paris, hôpital Louis-Mourier, université de Paris, 92700 Colombes, France; Inserm IAME-U1137, 75000 Paris, France; Groupe de recherche sur les infections pendant la grossesse (GRIG), 75000 Paris, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France; Infection Control Unit, Bichat University Hospital, Assistance publique-Hôpitaux de Paris, université de Paris, 75018 Paris, France. Electronic address: olivier.picone@aphp.fr.

Pub Type(s)

Journal Article

Language

fre

PubMed ID

32199996

Citation

Peyronnet, V, et al. "[SARS-CoV-2 Infection During Pregnancy. Information and Proposal of Management Care. CNGOF]." Gynecologie, Obstetrique, Fertilite & Senologie, vol. 48, no. 5, 2020, pp. 436-443.
Peyronnet V, Sibiude J, Deruelle P, et al. [SARS-CoV-2 infection during pregnancy. Information and proposal of management care. CNGOF]. Gynecol Obstet Fertil Senol. 2020;48(5):436-443.
Peyronnet, V., Sibiude, J., Deruelle, P., Huissoud, C., Lescure, X., Lucet, J. C., Mandelbrot, L., Nisand, I., Vayssière, C., Yazpandanah, Y., Luton, D., & Picone, O. (2020). [SARS-CoV-2 infection during pregnancy. Information and proposal of management care. CNGOF]. Gynecologie, Obstetrique, Fertilite & Senologie, 48(5), 436-443. https://doi.org/10.1016/j.gofs.2020.03.014
Peyronnet V, et al. [SARS-CoV-2 Infection During Pregnancy. Information and Proposal of Management Care. CNGOF]. Gynecol Obstet Fertil Senol. 2020;48(5):436-443. PubMed PMID: 32199996.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [SARS-CoV-2 infection during pregnancy. Information and proposal of management care. CNGOF]. AU - Peyronnet,V, AU - Sibiude,J, AU - Deruelle,P, AU - Huissoud,C, AU - Lescure,X, AU - Lucet,J-C, AU - Mandelbrot,L, AU - Nisand,I, AU - Vayssière,C, AU - Yazpandanah,Y, AU - Luton,D, AU - Picone,O, Y1 - 2020/03/19/ PY - 2020/03/16/received PY - 2020/3/23/pubmed PY - 2020/5/7/medline PY - 2020/3/23/entrez KW - COVID-19 KW - Coronavirus SARS-CoV-2 KW - Covid-19 KW - Grossesse KW - Maternal-fetal transmission KW - Newborn KW - Nouveau-né KW - Pregnancy KW - Transmission materno-fœtale SP - 436 EP - 443 JF - Gynecologie, obstetrique, fertilite & senologie JO - Gynecol Obstet Fertil Senol VL - 48 IS - 5 N2 - A new coronavirus (SARS-CoV-2) highlighted at the end of 2019 in China is spreading across all continents. Most often at the origin of a mild infectious syndrome, associating mild symptoms (fever, cough, myalgia, headache and possible digestive disorders) to different degrees, SARS-Covid-2 can cause serious pulmonary pathologies and sometimes death. Data on the consequences during pregnancy are limited. The first Chinese data published seem to show that the symptoms in pregnant women are the same as those of the general population. There are no cases of intrauterine maternal-fetal transmission, but cases of newborns infected early suggest that there could be vertical perpartum or neonatal transmission. Induced prematurity and cases of respiratory distress in newborns of infected mothers have been described. Pregnancy is known as a period at higher risk for the consequences of respiratory infections, as for influenza, so it seems important to screen for Covid-19 in the presence of symptoms and to monitor closely pregnant women. In this context of the SARS-Covid-2 epidemic, the societies of gynecology-obstetrics, infectious diseases and neonatalogy have proposed a French protocol for the management of possible and proven cases of SARS-Covid-2 in pregnant women. These proposals may evolve on a daily basis with the advancement of the epidemic and knowledge in pregnant women. Subsequently, an in-depth analysis of cases in pregnant women will be necessary in order to improve knowledge on the subject. SN - 2468-7189 UR - https://www.unboundmedicine.com/medline/citation/32199996/[SARS_CoV_2_infection_during_pregnancy__Information_and_proposal_of_management_care__CNGOF]_ DB - PRIME DP - Unbound Medicine ER -